Boundless Bio, Inc.

NasdaqGS:BOLD

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 24.40 M

Share Price

USD 1.09

Avg Daily Volume

74,090

Change (1 day)

1.87%

Change (1 year)

Change (YTD)

-50.90%

Boundless Bio, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2024: USD 0.00

Boundless Bio, Inc. Revenue is USD 0.00 for the Trailing 12 Months (TTM) ending December 31, 2024. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Boundless Bio, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 0.00.

Competitors

AbbVie Inc.

USD 187.63

ABBV

-1.65 -0.87%

Novo Nordisk A/S

USD 69.09

NOVO-B.CO

-1.99 -2.80%

Roche Holding AG

USD 342.25

RO.SW

-5.82 -1.67%

Novartis AG

USD 122.10

NOVN.SW

-1.46 -1.18%

Abbott Laboratories

USD 133.70

ABT

-0.74 -0.55%

AstraZeneca PLC

USD 138.95

AZN.L

-2.01 -1.43%

Merck & Co., Inc.

USD 80.90

MRK

-0.03 -0.04%

Amgen Inc.

USD 292.95

AMGN

-5.29 -1.77%

Pfizer Inc.

USD 25.24

PFE

-0.14 -0.55%

Gilead Sciences, Inc.

USD 111.78

GILD

+0.03 0.03%

Sanofi

USD 96.52

SAN.PA

-1.52 -1.55%

Vertex Pharmaceuticals Incorporated

USD 459.41

VRTX

-0.21 -0.05%

Bristol-Myers Squibb Company

USD 46.49

BMY

-0.43 -0.92%

Chugai Pharmaceutical Co., Ltd.

USD 47.25

4519.T

-1.65 -3.37%

GSK plc

USD 18.98

GSK.L

-0.18 -0.96%

CSL Limited

USD 160.25

CSL.AX

-0.71 -0.44%

Regeneron Pharmaceuticals, Inc.

USD 538.11

REGN

-9.25 -1.69%

MERCK Kommanditgesellschaft auf Aktien

USD 128.02

MRK.DE

-2.92 -2.23%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.45

600276.SS

+0.11 1.52%

Takeda Pharmaceutical Company Limited

USD 29.99

4502.T

-0.22 -0.74%

Key Data

Date	Revenue	Revenue	Gross Profit	Operating Income